日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Saccharomyces cerevisiae Polyphosphatidylinositol phosphatase INP53 (INP53), partial CSB-YP623599SVG
CSB-EP623599SVG
CSB-BP623599SVG
CSB-MP623599SVG
CSB-EP623599SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Exosome complex component RRP42 (RRP42) CSB-YP623600SVG
CSB-EP623600SVG
CSB-BP623600SVG
CSB-MP623600SVG
CSB-EP623600SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae FAD-linked sulfhydryl oxidase ERV2 (ERV2), partial CSB-YP623601SVG
CSB-EP623601SVG
CSB-BP623601SVG
CSB-MP623601SVG
CSB-EP623601SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YLR063W (YLR063W) CSB-YP623602SVG
CSB-EP623602SVG
CSB-BP623602SVG
CSB-MP623602SVG
CSB-EP623602SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized ABC transporter ATP-binding protein YDR061W (YDR061W), partial CSB-YP623603SVG
CSB-EP623603SVG
CSB-BP623603SVG
CSB-MP623603SVG
CSB-EP623603SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polaromonas sp. Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC) CSB-YP623604PAAI
CSB-EP623604PAAI
CSB-BP623604PAAI
CSB-MP623604PAAI
CSB-EP623604PAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Pre-mRNA-splicing factor CLF1 (CLF1), partial CSB-YP623605SVG
CSB-EP623605SVG
CSB-BP623605SVG
CSB-MP623605SVG
CSB-EP623605SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YOR021C (YOR021C) CSB-YP623606SVG
CSB-EP623606SVG
CSB-BP623606SVG
CSB-MP623606SVG
CSB-EP623606SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae GTPase-activating protein MSB4 (MSB4) CSB-YP623607SVG
CSB-EP623607SVG
CSB-BP623607SVG
CSB-MP623607SVG
CSB-EP623607SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Sulfate permease 2 (SUL2), partial CSB-YP623608SVG
CSB-EP623608SVG
CSB-BP623608SVG
CSB-MP623608SVG
CSB-EP623608SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Protein SCM3 (SCM3) CSB-YP623609SVG
CSB-EP623609SVG
CSB-BP623609SVG
CSB-MP623609SVG
CSB-EP623609SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Histone acetyltransferase type B catalytic subunit (HAT1) CSB-YP623610SVG
CSB-EP623610SVG
CSB-BP623610SVG
CSB-MP623610SVG
CSB-EP623610SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Uncharacterized protein YOR012W (YOR012W) CSB-YP623611SVG
CSB-EP623611SVG
CSB-BP623611SVG
CSB-MP623611SVG
CSB-EP623611SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Cell wall mannoprotein PST1 (PST1) CSB-YP623612SVG
CSB-EP623612SVG
CSB-BP623612SVG
CSB-MP623612SVG
CSB-EP623612SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Ribosomal N-lysine methyltransferase 5 (RKM5) CSB-YP623613SVG
CSB-EP623613SVG
CSB-BP623613SVG
CSB-MP623613SVG
CSB-EP623613SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Mitochondrial ornithine transporter 1 (ORT1), partial CSB-YP623614SVG1
CSB-EP623614SVG1
CSB-BP623614SVG1
CSB-MP623614SVG1
CSB-EP623614SVG1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Anaphase-promoting complex subunit SWM1 (SWM1) CSB-YP623615SVG
CSB-EP623615SVG
CSB-BP623615SVG
CSB-MP623615SVG
CSB-EP623615SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomyces cerevisiae Genetic interactor of prohibitin 5, mitochondrial (GEP5) CSB-YP623616SVG
CSB-EP623616SVG
CSB-BP623616SVG
CSB-MP623616SVG
CSB-EP623616SVG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polaromonas sp. Carboxylate-amine ligase Bpro_4470 (Bpro_4470) CSB-YP623617PAAI
CSB-EP623617PAAI
CSB-BP623617PAAI
CSB-MP623617PAAI
CSB-EP623617PAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Polaromonas sp. 50S ribosomal protein L10 (rplJ) CSB-YP623618PAAI
CSB-EP623618PAAI
CSB-BP623618PAAI
CSB-MP623618PAAI
CSB-EP623618PAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×